Bosh sahifaSWOBY • OTCMKTS
add
Swedish Orphan Biovitrum ADR
Yopilish kursi
17,30 $
Yillik diapazon
12,75 $ - 17,35 $
Bozor kapitalizatsiyasi
116,80 mlrd SEK
Oʻrtacha hajm
1,47 ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 7,78 mlrd | 12,79% |
Joriy xarajat | 3,41 mlrd | -3,26% |
Sof foyda | -2,89 mlrd | -297,68% |
Sof foyda marjasi | -37,22 | -275,24% |
Har bir ulushga tushum | 6,05 | 40,37% |
EBITDA | 10,32 mlrd | 243,54% |
Amaldagi soliq stavkasi | 28,12% | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,04 mlrd | 74,92% |
Jami aktivlari | 66,96 mlrd | -7,25% |
Jami passivlari | 30,98 mlrd | -11,70% |
Umumiy kapital | 35,98 mlrd | — |
Tarqatilgan aksiyalar | 344,66 mln | — |
Narxi/balansdagi bahosi | 0,17 | — |
Aktivlardan daromad | 10,33% | — |
Kapitaldan daromad | 13,82% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -2,89 mlrd | -297,68% |
Operatsiyalardan naqd pul | 1,84 mlrd | 53,21% |
Sarmoyadan naqd pul | -2,70 mlrd | -22,57% |
Moliyadan naqd pul | 857,00 mln | -0,35% |
Naqd pulning sof oʻzgarishi | -19,00 mln | 89,73% |
Boʻsh pul | 5,71 mlrd | 262,88% |
Haqida
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Tashkil etilgan
1939
Sayt
Xodimlar soni
1 890
